Results 131 to 140 of about 30,927 (236)

Near-tetraploidy is associated with Richter transformation in chronic lymphocytic leukemia patients receiving ibrutinib [PDF]

, 2017
Cecelia Miller, Amy S. Ruppert, Nyla A. Heerema, Kami J. Maddocks, Jadwiga Labanowska, H Breidenbach, Gerard Lozanski, Weiqiang Zhao, Amber Gordon, Jeffrey A. Jones, Joseph M. Flynn, Samantha Jaglowski, Leslie A. Andritsos, Kristie A. Blum, Farrukh T. Awan, Kerry A. Rogers, Michael R. Grever, Amy J. Johnson, Lynne V. Abruzzo, Erin Hertlein, James S. Blachly, Jennifer A. Woyach, John C. Byrd   +22 more
openalex   +1 more source

The Role of Tumor Microenvironment and Targeted Therapy in Chronic Lymphocytic Leukemia. [PDF]

Curr Issues Mol Biol
Saleh K, Arbab A, Khalife N, Khoury R, Ibrahim R, Hachem MA, Khalil C, Bou Orm C, Sawan J, Lafarge G, Masri N, Tikriti Z, Chahine C, Le Cesne A.   +13 more
europepmc   +1 more source

The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell Lymphoma

, 2016
Marco Ruella, Saad S. Kenderian, Olga Shestova, Joseph A. Fraietta, Sohail Qayyum, Qian Zhang, Marcela V. Maus, Xiaobin Liu, Selene Nuñez-Cruz, Michael Klichinsky, Omkar U. Kawalekar, Michael C. Milone, Simon F. Lacey, Anthony R. Mato, Stephen J. Schuster, Michael Kalos, Carl H. June, Saar Gill, Mariusz A. Wasik   +18 more
openalex   +1 more source

Ibrutinib versus previous standard of care: an adjusted comparison in patients with relapsed/refractory chronic lymphocytic leukaemia [PDF]

, 2017
Lotta Hansson, Anna Asklid, Joris Diels, Sandra Eketorp-Sylvan, Johanna Repits, Frans Søltoft, Ulrich Jäger, Anders Österborg   +7 more
openalex   +1 more source

Beyond Atrial Fibrillation and Heart Failure: Ibrutinib-induced Pericardial Effusion. [PDF]

J Community Hosp Intern Med Perspect
Singh A, Rucktuhl K, Panchal V, Ramadas P.   +3 more
europepmc   +1 more source

INTEGRATED ANALYSIS: OUTCOMES OF IBRUTINIB‐TREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LEUKEMIA (CLL/SLL) WITH HIGH‐RISK PROGNOSTIC FACTORS [PDF]

, 2017
Thomas J. Kipps, Graeme Fraser, Steven Coutré, Jennifer R. Brown, Jacqueline C. Barrientos, Paul M. Barr, John C. Byrd, Susan O’Brien, M.S. Dilhuydy, Peter Hillmen, Ulrich Jaeger, Carol Moreno, Paula Cramer, Stephan Stilgenbauer, A.A. Chanan‐Khan, Michelle Mahler, Mariya Salman, Minghua Cheng, Anil Londhe, Joi Ninomoto, Angela Howes, Danelle F. James, Michael Hallek   +22 more
openalex   +1 more source

The role of Janus kinase signaling in graft-versus-host disease and graft versus leukemia [PDF]

, 2018
Choi, Jaebok, DiPersio, John F, Schroeder, Mark A, Staser, Karl   +3 more
core   +2 more sources

Single-Agent Ibrutinib Demonstrates Efficacy and Safety in Patients with Relapsed/Refractory Marginal Zone Lymphoma: A Multicenter, Open-Label, Phase 2 Study

, 2016
Ariela Noy, Sven de Vos, Catherine Thiéblemont, Peter Martin, Christopher R. Flowers, Franck Morschhauser, Graham P. Collins, Shuo Ma, Morton Coleman, Shachar Peles, Stephen D. Smith, Alina Smith, Brian Munneke, Isaiah W. Dimery, Darrin M. Beaupre, Robert W. Chen   +15 more
openalex   +1 more source

Comparative Efficacy of Ibrutinib Versus Obinutuzumab + Chlorambucil in First-Line Treatment of Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison [PDF]

, 2017
Suzy Van Sanden, Simona Baculea, Joris Diels, Sarah Côté   +3 more
openalex   +1 more source

Long-term follow-up of MRD-guided ibrutinib plus venetoclax in relapsed CLL: phase 2 VISION/HO141 trial. [PDF]

Blood Adv
Niemann CU, Dubois J, Nasserinejad K, da Cunha-Bang C, Kersting S, Enggaard L, Veldhuis GJ, Mous R, Mellink CHM, van der Kevie-Kersemaekers AF, Dobber JA, Poulsen CB, Razawy W, Hollestein R, Frederiksen H, Janssens A, Schjødt I, Dompeling EC, Ranti J, Brieghel C, Mattsson M, Bellido M, Tran HTT, Kater AP, Levin MD.   +24 more
europepmc   +1 more source